Related Experiment Video
Updated: May 26, 2026

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
Published on: February 14, 2018
Intracellular concentrations of micafungin in different cellular compartments of the peripheral blood
Fedja Farowski1, Oliver A Cornely, Jörg J Vehreschild
1Universitätsklinikum Köln, Klinik I für Innere Medizin, Köln, Germany. Fedja.Farowski@ctuc.de
Abstract:
Whilst micafungin serum concentrations are well studied, little is known about its concentrations within cellular compartments of the peripheral blood. Hence, in this study blood samples were collected from patients receiving micafungin (n=26). These samples were separated by double-discontinuous Ficoll-Hypaque density gradient centrifugation. Intracellular concentrations within the obtained cells, i.e. peripheral blood mononuclear cells (PBMCs), polymorphonuclear leukocytes (PMNs) and red blood cells (RBCs), were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Within PBMCs and PMNs, the intracellular micafungin concentration was significantly increased compared with the concentration in plasma (P<0.001). The intracellular concentration within RBCs did not significantly differ from the plasma concentration. Micafungin reaches high concentrations in human PBMCs and PMNs and is present in RBCs. In vitro data showed that intracellular uptake of micafungin by PBMCs depends on the albumin concentration of the surrounding medium, but only at non-physiological protein concentrations.
Insights
Micafungin concentrates significantly within peripheral blood mononuclear cells (PBMCs) and polymorphonuclear leukocytes (PMNs), but not red blood cells (RBCs), in patients. This antifungal drug achieves high intracellular levels in key immune cells.
Area of Science:
- Pharmacokinetics
- Cellular Biology
- Infectious Diseases
Background:
- Micafungin is an echinocandin antifungal agent.
- Serum concentrations of micafungin are well-documented.
- Limited data exist on micafungin's intracellular distribution in peripheral blood cells.
Purpose of the Study:
- To quantify intracellular micafungin concentrations in peripheral blood cells.
- To compare intracellular concentrations with plasma levels.
- To investigate factors influencing micafungin uptake in peripheral blood mononuclear cells (PBMCs).
Main Methods:
- Blood samples were collected from 26 patients receiving micafungin.
- Peripheral blood mononuclear cells (PBMCs), polymorphonuclear leukocytes (PMNs), and red blood cells (RBCs) were isolated using Ficoll-Hypaque density gradient centrifugation.
- Intracellular micafungin concentrations were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Main Results:
- Intracellular micafungin concentrations were significantly higher in PBMCs and PMNs compared to plasma (P<0.001).
- Intracellular micafungin concentrations in RBCs did not differ significantly from plasma concentrations.
- In vitro studies indicated that albumin concentration affects PBMC uptake, but only at non-physiological levels.
Conclusions:
- Micafungin achieves substantial intracellular concentrations in human PBMCs and PMNs.
- Micafungin is present within RBCs, though not at elevated levels compared to plasma.
- The uptake of micafungin into PBMCs is influenced by albumin, particularly under non-physiological conditions, suggesting potential implications for drug distribution.
More Related Videos
Related Concept Videos
Pharmacodynamic Models: Overview
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Concentrations: Measurements
Plasma —...
Antifungal Agents

